Sex-dependent dopaminergic vulnerability may contribute to sex differences in Parkinson’s disease risk
By distinguishing baseline variation from age-related changes in a selectively vulnerable dopaminergic system, this study provides population-scale evidence relevant to understanding sex differences in vulnerability to Parkinson’s disease.